Company Data
Fulcrum Therapeutics Inc.
Ticker
FULC
Current Price
$8.29 3.75%
Market Cap
$552.1M
Price Target
Refer to Report
Volume
1.0M
52wk Range
$2.92 - $15.7399
Overview
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. It has developed a proprietary product engine that employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle-wasting disorder that leads to physical impairments and disability.